PT Phapros Tbk (IDX:PEHA)

Revenue by Segment

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Ethical	246.89B	159.34B	286.63B	372.69B	317.10B
Ethical Growth	54.94%	-44.41%	-23.09%	17.53%	42.35%
OGB (Generic Drugs Bearing)	485.21B	425.83B	515.55B	554.60B	537.56B
OGB (Generic Drugs Bearing) Growth	13.94%	-17.40%	-7.04%	3.17%	0.47%
OTC (Over The Counter)	197.78B	138.12B	183.28B	218.34B	173.25B
OTC (Over The Counter) Growth	43.20%	-24.64%	-16.05%	26.02%	-14.26%
Toll-In	11.00B	21.40B	18.11B	22.85B	23.53B
Toll-In Growth	-48.61%	18.16%	-20.74%	-2.88%	13.69%
Total	940.88B	744.69B	1.00T	1.17T	1.05T
Total Growth	26.34%	-25.80%	-14.11%	11.13%	7.23%

Revenue by Geography

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Indonesia	940.88B	744.69B	1.00T	1.17T	1.05T
Indonesia Growth	26.34%	-25.80%	-14.11%	11.13%	7.23%
Total	940.88B	744.69B	1.00T	1.17T	1.05T
Total Growth	26.34%	-25.80%	-14.11%	11.13%	7.23%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 21, 2026

Data Sources Report a data error